CN114558076A - Pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream and preparation method thereof - Google Patents
Pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream and preparation method thereof Download PDFInfo
- Publication number
- CN114558076A CN114558076A CN202210290138.4A CN202210290138A CN114558076A CN 114558076 A CN114558076 A CN 114558076A CN 202210290138 A CN202210290138 A CN 202210290138A CN 114558076 A CN114558076 A CN 114558076A
- Authority
- CN
- China
- Prior art keywords
- extract
- oil
- cattail pollen
- percentage
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000001398 Typha domingensis Species 0.000 title claims abstract description 41
- 239000006071 cream Substances 0.000 title claims abstract description 40
- 206010072170 Skin wound Diseases 0.000 title claims abstract description 35
- 230000023597 hemostasis Effects 0.000 title claims abstract description 16
- 230000036592 analgesia Effects 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 110
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 67
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims abstract description 24
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000008367 deionised water Substances 0.000 claims abstract description 22
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 22
- 241000241413 Propolis Species 0.000 claims abstract description 21
- 229940069949 propolis Drugs 0.000 claims abstract description 21
- -1 alkyl glucoside Chemical class 0.000 claims abstract description 16
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 16
- 230000000202 analgesic effect Effects 0.000 claims abstract description 16
- 230000002439 hemostatic effect Effects 0.000 claims abstract description 16
- 241001106067 Atropa Species 0.000 claims abstract description 15
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 15
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 15
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 15
- 241000931705 Cicada Species 0.000 claims abstract description 14
- 235000011477 liquorice Nutrition 0.000 claims abstract description 14
- 244000306301 Caesalpinia sappan Species 0.000 claims abstract description 13
- 235000015162 Caesalpinia sappan Nutrition 0.000 claims abstract description 13
- 244000144927 Aloe barbadensis Species 0.000 claims abstract description 12
- 235000002961 Aloe barbadensis Nutrition 0.000 claims abstract description 12
- 241000972672 Phellodendron Species 0.000 claims abstract description 12
- 235000013871 bee wax Nutrition 0.000 claims abstract description 12
- 239000012166 beeswax Substances 0.000 claims abstract description 12
- 229960000541 cetyl alcohol Drugs 0.000 claims abstract description 12
- 239000003240 coconut oil Substances 0.000 claims abstract description 12
- 235000019864 coconut oil Nutrition 0.000 claims abstract description 12
- 239000002285 corn oil Substances 0.000 claims abstract description 12
- 235000005687 corn oil Nutrition 0.000 claims abstract description 12
- 235000021323 fish oil Nutrition 0.000 claims abstract description 12
- 239000012530 fluid Substances 0.000 claims abstract description 12
- 229930182478 glucoside Natural products 0.000 claims abstract description 12
- 229940075507 glyceryl monostearate Drugs 0.000 claims abstract description 12
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims abstract description 12
- 239000008159 sesame oil Substances 0.000 claims abstract description 12
- 235000011803 sesame oil Nutrition 0.000 claims abstract description 12
- 241001474374 Blennius Species 0.000 claims abstract description 4
- 239000003921 oil Substances 0.000 claims description 48
- 235000019198 oils Nutrition 0.000 claims description 48
- 239000002994 raw material Substances 0.000 claims description 26
- 238000003756 stirring Methods 0.000 claims description 10
- 238000005303 weighing Methods 0.000 claims description 10
- 239000003995 emulsifying agent Substances 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000003825 pressing Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 240000007124 Brassica oleracea Species 0.000 claims description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 2
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 2
- 239000002537 cosmetic Substances 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 abstract description 20
- 230000036407 pain Effects 0.000 abstract description 20
- 230000029663 wound healing Effects 0.000 abstract description 13
- 230000000740 bleeding effect Effects 0.000 abstract description 11
- 229920001213 Polysorbate 20 Polymers 0.000 abstract description 4
- 241000411851 herbal medicine Species 0.000 abstract description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 abstract description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 abstract description 4
- 229940068977 polysorbate 20 Drugs 0.000 abstract description 4
- 238000000199 molecular distillation Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 35
- 206010052428 Wound Diseases 0.000 description 26
- 208000027418 Wounds and injury Diseases 0.000 description 26
- 230000001737 promoting effect Effects 0.000 description 23
- 239000003814 drug Substances 0.000 description 16
- 208000032843 Hemorrhage Diseases 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 208000003251 Pruritus Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 230000003179 granulation Effects 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 239000002674 ointment Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 241001116389 Aloe Species 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 206010033474 Pain of skin Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000017423 tissue regeneration Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 235000007650 Aralia spinosa Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 244000301850 Cupressus sempervirens Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010012442 Dermatitis contact Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 240000001624 Espostoa lanata Species 0.000 description 2
- 235000009161 Espostoa lanata Nutrition 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010017711 Gangrene Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 241000949456 Zanthoxylum Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 208000010247 contact dermatitis Diseases 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 206010009152 Chronic tonsillitis Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000972673 Phellodendron amurense Species 0.000 description 1
- 206010036410 Postoperative wound infection Diseases 0.000 description 1
- 241000256626 Pterygota <winged insects> Species 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 206010041303 Solar dermatitis Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 208000031650 Surgical Wound Infection Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 235000004224 Typha angustifolia Nutrition 0.000 description 1
- 241001518821 Typha orientalis Species 0.000 description 1
- 241000233945 Typhaceae Species 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000922 anti-bactericidal effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- KCUZCRLRQVRBBV-UHFFFAOYSA-N licoisoflavone A Chemical class CC(C)=CCC1=C(O)C=CC(C=2C(C3=C(O)C=C(O)C=C3OC=2)=O)=C1O KCUZCRLRQVRBBV-UHFFFAOYSA-N 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- MOCOXAJEZKHXSF-IHMBCTQLSA-M sodium;(2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound [Na+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MOCOXAJEZKHXSF-IHMBCTQLSA-M 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The invention discloses a pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream which comprises propolis, molecular distillation sesame oil, cosmetic-grade corn oil, coconut oil, cetyl alcohol, beeswax, deep sea fish oil, edible glyceryl monostearate, honeycomb element extract, nidus vespae extract, cattail pollen extract, spiny seaweed extract, belladonna extract, liquorice fluid extract, aloe vera, phellodendron extract, Chinese herbal medicine extracts such as sappan wood, cicada slough and the like, T-20 (polysorbate-20), alkyl glucoside (C12-18) and deionized water. Simultaneously discloses a preparation method of the pure natural cattail pollen honeycomb element skin wound hemostatic and analgesic cream. The invention can be directly applied to the damaged part of the skin wound to stop bleeding, relieve pain and promote the wound healing, and solves the problem that the prior art can not meet the special requirements of the family self-treatment of the skin wound or the external rehabilitation after the operation.
Description
Technical Field
The invention relates to a cream, in particular to a pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream and a preparation method thereof, belonging to the technical field of traditional Chinese medicine creams.
Background
Skin trauma generally refers to the destruction of skin tissue and the possible systemic reactions that occur as a result of various factors. In recent years, the external traditional Chinese medicine has a great progress in treating various types of skin wounds, more and more traditional Chinese medicines are used in clinic, and a better clinical effect is achieved, and people gradually pay attention to the function of the traditional Chinese medicine in treating the wounds
In traditional Chinese medicine, the contents of wound healing can be summarized in the category of incised wound, the contents are rich, the history is long, and doctors of all ages also accumulate certain clinical experience. The traditional Chinese medicine is externally used for promoting wound healing, has unique curative effect, takes the main treatment principles of promoting qi and activating blood circulation, promoting the growth of new tissue, eliminating dampness and recovering pus, removing pus and muscle, promoting the healing of acerbity and promoting tissue regeneration and healing wound as well as exerts multi-target, multi-link and multi-level comprehensive regulation and control effects on main influence factors of wound healing, and has obvious effect.
In clinical skin trauma applications, an ointment is the most common dosage form. The ointment is externally applied to the wound, and the isolation effect can effectively avoid external bacterial infection and stimulation, promote the improvement of local blood pressure circulation of the affected part and the repair and regeneration of wound tissues as soon as possible.
In recent years, the external medicine for treating skin wounds has been developed to a certain extent. However, due to the lack of special varieties, the special requirements of home self-treatment of skin wounds or external rehabilitation after operation cannot be met.
Disclosure of Invention
The invention aims to overcome the defects in the prior art and provides the pure natural cattail pollen honeycomb element skin wound hemostatic and analgesic cream and the preparation method thereof.
In order to solve the problems, the invention adopts the following technical scheme: a pure natural cattail pollen honeycomb element skin wound hemostasis analgesic cream comprises 24-24.5% of oil phase and 75.5-76% of water phase according to weight percentage;
the oil phase comprises the following components in percentage by weight: 1.5-2.0% of propolis, 1.5-2.0% of molecular distilled sesame oil, 7.0-8% of cosmetic-grade corn oil, 2-3% of coconut oil, 4.0-5% of cetyl alcohol, 1.5-2% of beeswax, 1.5-2% of deep sea fish oil and 2.0-2.5% of edible glyceryl monostearate;
the water phase comprises the following components in percentage by weight: 2.0-2.5% of beehive extract, 1.5% of nidus vespae extract, 3.0-3.5% of cattail pollen extract, 1.5% of spiny cabbage extract, 1.5-2.5% of belladonna extract, 1.5-3.0% of liquorice fluid extract, 2.5-3.0% of aloe barbadensis, 1.0-1.5% of phellodendron extract, 1.0-1.5% of sappan wood extract, 0.5-1.0% of cicada slough extract, 1.5% of T-201.0-1.5% of alkyl glucoside and 51.5-56.0% of deionized water.
The following is a further optimization of the present invention to the above scheme: a pure natural pollen Typhae honeycomb essence cream for stopping bleeding and relieving pain of skin wound comprises oil phase 24.5% and water phase 75.5%;
the oil phase comprises the following components in percentage by weight: 1.5% of propolis, 2.0% of molecular distilled sesame oil, 8% of cosmetic-grade corn oil, 2% of coconut oil, 5% of cetyl alcohol, 2% of beeswax, 2% of deep sea fish oil and 2.0% of edible glyceryl monostearate;
the water phase comprises the following components in percentage by weight: 2.0% of beehive extract, 1.5% of nidus vespae extract, 3.0% of cattail pollen extract, 1.5% of spiny seaweed extract, 1.5% of belladonna extract, 1.5% of liquorice fluid extract, 3.0% of aloe barbadensis, 1.0% of phellodendron extract, 1.5% of sappan wood extract, 0.5% of cicada slough extract, T-201.0%, 1.5% of alkyl glucoside and 56.0% of deionized water.
And (4) further optimizing: a pure natural cattail pollen honeycomb element skin wound hemostasis analgesic cream comprises 24% of oil phase and 76% of water phase by weight percent;
the oil phase comprises the following components in percentage by weight: 2.0% of propolis, 1.5% of molecular distilled sesame oil, 8.0% of cosmetic-grade corn oil, 3.0% of coconut oil, 4.5% of cetyl alcohol, 1.5% of beeswax, 1.5% of deep sea fish oil and 2.0% of edible glyceryl monostearate;
the water phase comprises the following components in percentage by weight: 2.5 percent of beehive extract, 1.5 percent of nidus vespae extract, 3.5 percent of cattail pollen extract, 1.5 percent of spiny pricklyash root extract, 2.5 percent of belladonna extract, 2.5 percent of liquorice fluid extract, 2.5 percent of aloe barbadensis, 1.5 percent of phellodendron extract, 1.0 percent of sappan wood extract, 1.0 percent of cicada slough extract, T-201.5 percent, 1.5 percent of alkyl glucoside and 53.0 percent of deionized water.
The invention also discloses a pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream which comprises 24.5 percent of oil phase and 75.5 percent of water phase by weight percent;
the oil phase comprises the following components in percentage by weight: 2.0% of propolis, 2.0% of molecular distilled sesame oil, 7.0% of cosmetic corn oil, 3.0% of coconut oil, 4.0% of cetyl alcohol, 2.0% of beeswax, 2.0% of deep sea fish oil and 2.5% of edible glyceryl monostearate;
the water phase comprises the following components in percentage by weight: 2.5% of beehive extract, 1.5% of nidus vespae extract, 3.5% of cattail pollen extract, 1.5% of spiny prickly ash extract, 2.5% of belladonna extract, 3.0% of liquorice fluid extract, 3.0% of aloe barbadensis, 1.5% of phellodendron extract, 1.5% of sappan wood extract, 1.0% of cicada slough extract, T-201.0%, 1.5% of alkyl glucoside and 51.5% of deionized water.
Simultaneously discloses a preparation method of the pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream, which comprises the following steps:
(1) weighing raw materials of each component in the oil phase according to the weight percentage, adding the raw materials into a preheating tank, controlling the temperature to be between 70 and 80 ℃, and starting stirring until the oil phase is completely melted when the oil phase is melted;
(2) weighing raw material components and deionized water in the water phase according to the weight percentage, adding the raw material components and deionized water into a water phase preheating tank, heating, starting stirring, and keeping the temperature between 70 ℃ and 80 ℃ to completely dissolve the raw materials;
(3) keeping the temperature of the oil phase and the water phase, pressing the oil phase and the water phase into a homogenizing emulsifier through a pipeline with a filter screen, mixing, homogenizing and emulsifying to obtain the product.
The excellent effects of the present invention are as follows:
1. the traditional Chinese medicine of cattail pollen and honeycomb element are compounded, the application of the traditional Chinese medicine of cattail pollen and honeycomb element in the cream for treating skin wounds is not reported, and the research of the cream in the patent opens a creative new mode;
the pollen Typhae is an excellent hemostatic, and is dried pollen of Typha angustifolia, Typha orientalis or congeneric plants of Typhaceae;
pollen Typhae for treating traumatic hemorrhage can be used alone for external wound, has effects of promoting blood circulation, removing blood stasis, and treating stranguria, and can be used for external treatment of traumatic injury, pollen Typhae has hemostatic effect, and has hemostatic effect without blood stasis;
the cattail pollen has the efficacy of activating blood, is clinically used for treating various pains caused by blood stasis, can treat ear purulence, water flowing or vulvar pruritus caused by aphtha or in-ear eczema and otitis media, and is a good medicine for stopping bleeding and easing pain of skin wounds and promoting wound healing.
2. The honeycomb element, the nidus vespae and the propolis can naturally ease pain and promote tissue regeneration, and play a synergistic effect of easing pain, resisting inflammation and promoting wound healing in the cream;
the honeycomb element is prepared by extracting effective components from honeycomb and refining, can be used for treating sore carbuncle pyogenic infections, acute mastitis swelling and pain, scrofula subcutaneous nodule, stubborn tinea, cancerous swelling and pain and the like, and has the effects of resisting inflammation, easing pain, promoting blood coagulation, reducing blood pressure, expanding blood vessels, strengthening heart, resisting cancer, resisting bacteria, reducing temperature, expelling ascarid and winged insect and is commonly used for treating various diseases such as pyogenic infection, acute mastitis, neurodermatitis, toothache, dysentery, enuresis, pertussis, chronic bronchitis and the like;
nidus Vespae extract has effects of dispelling rash, pruritus and relieving pain; swelling-eliminating rose venom for treating pyogenic infection; killing parasites to relieve itching, and relieving arthralgia due to wind-heat; carbuncle, deep-rooted carbuncle and malignant sore; scrofula (eczema); swelling and pain of the throat and tongue; hemorrhoids and fistula; wind itching; intractable skin tinea; the nidus Vespae added into the cream has certain curative effects on traumatic infection, postoperative wound infection, furuncle, carbuncle, scald, cellulitis, subcutaneous gangrene of newborn and the like, is particularly more effective on gangrene (ulcerated) and suppurative sore surfaces, has the functions of removing necrosis, promoting granulation, diminishing inflammation, relieving pain and the like, and can promote the wound to be as soon as possible;
propolis is a traditional natural medicine, and has wide pharmacological activity and wound healing effect;
the application history of the propolis in Europe has been over 2000 years, and the propolis is currently collected in pharmacopoeia of the people's republic of China, and the functions and the main treatment of the propolis are determined as follows: tonifying deficiency, eliminating turbid fat, and relieving diabetes; the external use detoxifies detumescence, astringes and promotes granulation, and is used for treating body deficiency, senilism, hyperlipoidemia and diabetes; the propolis has excellent anti-inflammatory and bactericidal effects, so that more and more scientists begin to apply the propolis to the field of wound healing research, and the addition of the propolis into the cream ensures that the cream has the effects of detoxifying, healing sore, promoting granulation and relieving pain, has good treatment effects on skin wounds and postoperative wounds, is commonly used for rehabilitation treatment of unhealed ulcer, ecthyma erosion, traumatic ulceration and burn and scald, and has good effects on anesthesia and analgesia.
3. Effect and action of Roxburgh herbs
The spiny vegetable traditional Chinese medicine is named as herba cephalanoploris, is a high-quality wild vegetable, has strong adaptability, can grow under any weather conditions, is common weed, is sweet and cool in nature and tastes cool, enters heart, liver, lung and stomach channels, has the effects of cooling blood and stopping bleeding and clearing heat and toxic materials, has the effect of cooling blood and stopping bleeding, is mainly used by causing local vasoconstriction and inhibiting fibrinolysis, has good effects of clearing heat and removing toxicity, and can be used for treating heat-toxin sore swelling and traumatic hemorrhage.
4. Belladonna grass extract with excellent pain relieving and granulation promoting effects
Belladonna grass has the functions of inhibiting secretion, anaesthetizing, relieving pain, promoting blood circulation and removing blood stasis, and can be used for treating traumatic injury, carbuncle, sore and pyogenic infections, and is easy to astringe and heal wound surfaces.
5. Licorice plays an important role in the formula
Glycyrrhizin and licoisoflavone compounds in Glycyrrhrizae radix have effect in inhibiting HIV proliferation; glycyrrhrizae radix has antivirus effect, and Glycyrrhrizae radix alcohol extract and sodium glycyrrhetate have antibacterial effect; the liquorice has anti-inflammatory effect, has good curative effect on patients suffering from skin ulcer, rhagadia manus et pedis, solar dermatitis, contact dermatitis and frostbite ulcer complicated infection by modern clinical external application, has the advantages of fading of red swelling, stopping seepage and healing of erosion face in 1-4 days of treating contact dermatitis generally, and also has good effect on treating allergic dermatitis.
6. Aloe has excellent skin injury repairing effect
The aloe gel has the effects of protecting skin, promoting wound healing, diminishing inflammation and sterilizing, has a plurality of external effects and efficacies, can protect skin on one hand, and can diminish inflammation and sterilize on the other hand, when the juice of the aloe is prepared into a polysaccharide preparation for skin or other tissue wounds and the like, the aloe gel has good effects of moisturizing, preventing sunburn and promoting wound healing, has good skin-care effect, can not only replenish moisture for the skin, but also prevent aging, can relieve nerves, calm the skin, kill bacteria and well keep moisture due to good bacteriostatic effect, can lead the skin to become tender due to insisting on, simultaneously has a certain spot-lightening effect, contains a certain whitening component and a certain collagen component, can repair damaged skin and lead the skin to become plump, Reducing the generation of wrinkles.
7. The phellodendron bark has obvious effects of detoxifying and treating sore
The golden cypress is a heat-clearing medicine, has the effects of clearing heat, drying dampness, purging fire, removing steam, detoxifying and treating sore, can detoxify and treat sore, and is clinically used for treating carbuncle ulcer and furuncle caused by excessive fire-heat toxin;
in Bencao Shiyi, it is indicated for treating herpes zoster, insect sore, dysentery, hematochezia and moth;
rihuazi Bencao states that "Anxin removes fatigue, cures bone steaming, washes liver, improves eyesight, tears, dry mouth, heart heat, kills infantile malnutrition worms, cures ascarid heartache, scabies, cures nose flood, intestinal wind, purges blood, and is divided into acute heat swelling and pain after that. "
8. Cicada slough
The medicine has the effects of resisting convulsion, calming, relieving fever, resisting allergy, suppressing immunity and relieving pain, can be used for treating acute and chronic tonsillitis, cough, night cry of infants, urticaria, various skin pruritus and other diseases, dispelling wind and removing heat, relieving sore throat, promoting eruption, removing nebula and relieving spasm, and is used for treating wind-heat type common cold, pharyngalgia, hoarseness, measles without adequate eruption, rubella pruritus, conjunctival congestion, nebula, convulsion and tetanus;
in a word, the pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream has excellent effects of promoting blood circulation to remove blood stasis, relieving swelling and pain, clearing heat and removing toxicity, and promoting tissue regeneration and healing, can effectively promote blood circulation of a wound part, promotes the penetration and absorption of medicaments in local tissues from the outside to the inside, and achieves the purposes of dredging channels and collaterals, promoting blood circulation to remove blood stasis and relieving pain; the medicine can directly contact with wound, and is beneficial to clearing heat, detumescence, removing putrefaction, promoting granulation, and promoting wound healing; in addition, the cattail pollen honeycomb element oil-in-water emulsifiable paste has the advantages of fine paste, excellent skin-friendly performance, easy coating after expansion, long detention time, easy absorption by wounds, good stability, naturalness, safety and no toxic or side effect.
The invention has excellent effects of stopping bleeding, easing pain, resisting inflammation, eliminating decay, promoting wound healing and repairing wound surface, and can be widely applied to the treatment of skin wound and the rehabilitation treatment of auxiliary operation wound surface;
the invention is composed of natural substrate raw materials, endows the cream with excellent skin affinity, softness, tastelessness, smoothness, no stimulation, is suitable for all groups including pregnant women, and can be used in large area;
the ointment is prepared by adopting a mild surface emulsifier, is fine and smooth, can be directly applied to wounds, has a good isolation effect, and is safe and non-irritant;
the invention is easy to coat in oil-in-water dosage form; can be effectively fused with the wound and is convenient to carry; does not pollute clothes, and is suitable for people of all ages.
The invention is further illustrated with reference to the following figures and examples.
Drawings
FIG. 1 is a result of testing physicochemical indexes of a pure natural pollen Typhae comb element cream for stopping bleeding and easing pain of skin wounds.
Detailed Description
Example 1, a pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream comprises 24.5 percent of oil phase and 75.5 percent of water phase by weight percent;
the oil phase comprises the following components in percentage by weight: 1.5% of propolis, 2.0% of molecular distilled sesame oil, 8% of cosmetic-grade corn oil, 2% of coconut oil, 5% of cetyl alcohol, 2% of beeswax, 2% of deep sea fish oil and 2.0% of edible glyceryl monostearate;
the water phase comprises the following components in percentage by weight: 2.0% of beehive extract, 1.5% of nidus vespae extract, 3.0% of cattail pollen extract, 1.5% of cephalanoplos chinensis (herba cephalanoploris) extract, 1.5% of belladonna extract, 1.5% of liquorice fluid extract, 3.0% of aloe vera, 1.0% of phellodendron extract, 1.5% of sappan wood extract, 0.5% of cicada slough, 1.0% of T-20 (polysorbate-20), 1.5% of alkyl glucoside (C12-18) and 56.0% of deionized water.
The preparation method of the pure natural cattail pollen honeycomb element skin wound hemostatic and analgesic cream comprises the following steps: (1) weighing raw materials of each component in the oil phase according to the weight percentage, adding the raw materials into a preheating tank, controlling the temperature to be between 70 and 80 ℃, and starting stirring until the oil phase is completely melted when the oil phase is melted;
(2) weighing raw material components and deionized water in the water phase according to the weight percentage, adding the raw material components and the deionized water into a water phase preheating tank, heating, starting stirring, and keeping the temperature between 70 ℃ and 80 ℃ to completely dissolve the raw materials;
(3) keeping the temperature of the oil phase and the water phase, pressing the oil phase and the water phase into a homogenizing emulsifier through a pipeline with a filter screen, mixing, homogenizing and emulsifying to obtain the product.
Example 2, a pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream, which comprises 24% of oil phase and 76% of water phase by weight percentage;
the oil phase comprises the following components in percentage by weight: 2.0% of propolis, 1.5% of molecular distilled sesame oil, 8.0% of cosmetic-grade corn oil, 3.0% of coconut oil, 4.5% of cetyl alcohol, 1.5% of beeswax, 1.5% of deep sea fish oil and 2.0% of edible glyceryl monostearate;
the water phase comprises the following components in percentage by weight: 2.5% of beehive extract, 1.5% of nidus vespae extract, 3.5% of cattail pollen extract, 1.5% of cephalanoplos chinensis (herba cephalanoploris) extract, 2.5% of belladonna extract, 2.5% of liquorice fluid extract, 2.5% of aloe vera, 1.5% of phellodendron extract, 1.0% of sappan wood extract, 0.5% of cicada slough extract, 1.5% of T-20 (polysorbate-20), 1.5% of alkyl glucoside (C12-18) and 53.0% of deionized water.
The preparation method of the pure natural cattail pollen honeycomb element skin wound hemostatic and analgesic cream comprises the following steps: (1) weighing raw materials of each component in the oil phase according to the weight percentage, adding the raw materials into a preheating tank, controlling the temperature to be between 70 and 80 ℃, and starting stirring until the oil phase is completely melted when the oil phase is melted;
(2) weighing raw material components and deionized water in the water phase according to the weight percentage, adding the raw material components and the deionized water into a water phase preheating tank, heating, starting stirring, and keeping the temperature between 70 ℃ and 80 ℃ to completely dissolve the raw materials;
(3) keeping the temperature of the oil phase and the water phase, pressing the oil phase and the water phase into a homogenizing emulsifier through a pipeline with a filter screen, mixing, homogenizing and emulsifying to obtain the product.
Example 3, a pure natural cattail pollen honeycomb element skin wound hemostatic and analgesic cream comprises 24.5% of oil phase and 75.5% of water phase by weight percentage;
the oil phase comprises the following components in percentage by weight: 2.0% of propolis, 2.0% of molecular distilled sesame oil, 7.0% of cosmetic-grade corn oil, 3.0% of coconut oil, 4.0% of cetyl alcohol, 2.0% of beeswax, 2.0% of deep sea fish oil and 2.5% of edible glyceryl monostearate;
the water phase comprises the following components in percentage by weight: 2.5% of beehive extract, 1.5% of nidus vespae extract, 3.5% of cattail pollen extract, 1.5% of cephalanoplos chinensis (herba cephalanoploris) extract, 2.5% of belladonna extract, 3.0% of liquorice fluid extract, 3.0% of aloe vera, 1.5% of phellodendron extract, 1.5% of sappan wood extract, 1.0% of cicada slough extract, 1.0% of T-20 (polysorbate-20), 1.5% of alkyl glucoside (C12-18) and 51.5% of deionized water.
The preparation method of the pure natural cattail pollen honeycomb element skin wound hemostatic and analgesic cream comprises the following steps: (1) weighing raw materials of each component in the oil phase according to the weight percentage, adding the raw materials into a preheating tank, controlling the temperature to be between 70 and 80 ℃, and starting stirring until the oil phase is completely melted when the oil phase is melted;
(2) weighing raw material components and deionized water in the water phase according to the weight percentage, adding the raw material components and the deionized water into a water phase preheating tank, heating, starting stirring, and keeping the temperature between 70 ℃ and 80 ℃ to completely dissolve the raw materials;
(3) keeping the temperature of the oil phase and the water phase, pressing the oil phase and the water phase into a homogenizing emulsifier through pipelines with filter screens respectively, mixing, homogenizing and emulsifying to obtain the product.
Example 4, the application method of the pure natural pollen typhae honeycomb element skin wound hemostasis and analgesia cream comprises the steps of dipping a little by a cotton stick or a cotton ball absorbent, and directly applying the cream to a wound or a ulcerated and rotten wound;
if bleeding occurs, the ointment can be dipped in cotton ball and then attached to the wound for staying, and after the bleeding stops, the ointment is taken again and applied again.
The honeycomb element Chinese herbal medicine component hemostatic and analgesic cream has excellent hemostatic, analgesic, antibacterial, wound-astringing and wound-healing promoting performances and good user feedback after being used by people of all ages, various skin wounds and postoperative groups, and is accepted and reputed by patients.
Performance testing
The performance detection of the pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream is carried out according to the QB/T1857-2013 cosmetic cream standard, and the quality and performance of the products of examples 1-3 can reach the standard requirements.
The test results of physical and chemical indexes of a pure natural pollen typhae honeycomb element skin wound hemostatic and analgesic cream are shown in figure 1.
A Chinese herbal medicine component hemostatic and analgesic cream of pollen typhae honeycomb element is prepared by taking pollen typhae, honeycomb element, nidus vespae and propolis as main analgesic and anti-inflammatory components and taking traditional Chinese herbal medicine extract of liquorice, belladonna, golden cypress, sappan wood, cicada slough and the like which are used for stopping bleeding, relieving pain and astringing wounds as auxiliary materials, relates to two aspects of medicine compatibility and paste matrix formula of medical theory, belongs to two different technical fields, the cattail pollen honeycomb element hemostatic and analgesic cream of the invention is successfully researched, has the functions of stopping bleeding, easing pain, resisting inflammation, astringing wound and assisting the recovery of skin wound after operation for consumers, has unique effect on the treatment of skin diseases such as sores and carbuncles, and the like, is successfully developed, the method can create good economic and social benefits for enterprises while bringing good news to people.
Claims (5)
1. A pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream is characterized in that: comprises 24 to 24.5 percent of oil phase and 75.5 to 76 percent of water phase according to weight percentage;
the oil phase comprises the following components in percentage by weight: 1.5-2.0% of propolis, 1.5-2.0% of molecular distilled sesame oil, 7.0-8% of cosmetic-grade corn oil, 2-3% of coconut oil, 4.0-5% of cetyl alcohol, 1.5-2% of beeswax, 1.5-2% of deep sea fish oil and 2.0-2.5% of edible glyceryl monostearate;
the water phase comprises the following components in percentage by weight: 2.0-2.5% of beehive extract, 1.5% of nidus vespae extract, 3.0-3.5% of cattail pollen extract, 1.5% of spiny cabbage extract, 1.5-2.5% of belladonna extract, 1.5-3.0% of liquorice fluid extract, 2.5-3.0% of aloe barbadensis, 1.0-1.5% of phellodendron extract, 1.0-1.5% of sappan wood extract, 0.5-1.0% of cicada slough extract, 1.5% of T-201.0-1.5% of alkyl glucoside and 51.5-56.0% of deionized water.
2. The pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream as claimed in claim 1, which is characterized in that: comprises 24.5 percent of oil phase and 75.5 percent of water phase according to weight percentage;
the oil phase comprises the following components in percentage by weight: 1.5% of propolis, 2.0% of molecular distilled sesame oil, 8% of cosmetic-grade corn oil, 2% of coconut oil, 5% of cetyl alcohol, 2% of beeswax, 2% of deep sea fish oil and 2.0% of edible glyceryl monostearate;
the water phase comprises the following components in percentage by weight: 2.0% of beehive extract, 1.5% of nidus vespae extract, 3.0% of cattail pollen extract, 1.5% of spiny seaweed extract, 1.5% of belladonna extract, 1.5% of liquorice fluid extract, 3.0% of aloe barbadensis, 1.0% of phellodendron extract, 1.5% of sappan wood extract, 0.5% of cicada slough extract, T-201.0%, 1.5% of alkyl glucoside and 56.0% of deionized water.
3. The pure natural cattail pollen honeycomb element skin wound hemostatic and analgesic cream as claimed in claim 1, which is characterized in that: comprises 24 percent of oil phase and 76 percent of water phase according to weight percentage;
the oil phase comprises the following components in percentage by weight: 2.0% of propolis, 1.5% of molecular distilled sesame oil, 8.0% of cosmetic-grade corn oil, 3.0% of coconut oil, 4.5% of cetyl alcohol, 1.5% of beeswax, 1.5% of deep sea fish oil and 2.0% of edible glyceryl monostearate;
the water phase comprises the following components in percentage by weight: 2.5% of beehive extract, 1.5% of nidus vespae extract, 3.5% of cattail pollen extract, 1.5% of spiny dock extract, 2.5% of belladonna extract, 2.5% of liquorice fluid extract, 2.5% of aloe barbadensis, 1.5% of phellodendron extract, 1.0% of sappan wood extract, 1.0% of cicada slough extract, T-201.5%, 1.5% of alkyl glucoside and 53.0% of deionized water.
4. The pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream as claimed in claim 1, which is characterized in that: comprises 24.5 percent of oil phase and 75.5 percent of water phase according to weight percentage;
the oil phase comprises the following components in percentage by weight: 2.0% of propolis, 2.0% of molecular distilled sesame oil, 7.0% of cosmetic corn oil, 3.0% of coconut oil, 4.0% of cetyl alcohol, 2.0% of beeswax, 2.0% of deep sea fish oil and 2.5% of edible glyceryl monostearate;
the water phase comprises the following components in percentage by weight: 2.5% of beehive extract, 1.5% of nidus vespae extract, 3.5% of cattail pollen extract, 1.5% of spiny seaweed extract, 2.5% of belladonna extract, 3.0% of liquorice fluid extract, 3.0% of aloe barbadensis, 1.5% of phellodendron extract, 1.5% of sappan wood extract, 1.0% of cicada slough extract, T-201.0%, 1.5% of alkyl glucoside and 51.5% of deionized water.
5. The method for preparing the pure natural cattail pollen honeycomb element skin wound hemostatic and analgesic cream as claimed in any one of claims 1 to 4, characterized in that: the method comprises the following steps: (1) weighing the raw materials of each component in the oil phase according to the weight percentage, adding the raw materials into an oil phase preheating tank, controlling the temperature to be between 70 and 80 ℃, and starting stirring until the oil phase is completely melted when the oil phase is melted;
(2) weighing raw material components and deionized water in the water phase according to the weight percentage, adding the raw material components and the deionized water into a water phase preheating tank, heating, starting stirring, and keeping the temperature between 70 ℃ and 80 ℃ to completely dissolve the raw materials;
(3) keeping the temperature of the oil phase and the water phase, pressing the oil phase and the water phase into a homogenizing emulsifier through pipelines with filter screens respectively, mixing, homogenizing and emulsifying to obtain the product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210290138.4A CN114558076A (en) | 2022-03-23 | 2022-03-23 | Pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210290138.4A CN114558076A (en) | 2022-03-23 | 2022-03-23 | Pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114558076A true CN114558076A (en) | 2022-05-31 |
Family
ID=81718847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210290138.4A Pending CN114558076A (en) | 2022-03-23 | 2022-03-23 | Pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114558076A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101596310A (en) * | 2008-06-02 | 2009-12-09 | 彭强 | A kind of artificial substrate membrane emulsifying paste that is used for wound repair |
CN104940849A (en) * | 2015-07-29 | 2015-09-30 | 青岛蓝盛洋医药生物科技有限责任公司 | Traditional Chinese medicine preparation for treating boils through external application and preparation method of traditional Chinese medicine preparation |
CN105963518A (en) * | 2016-03-21 | 2016-09-28 | 经雷 | External-use liniment for treating scald |
-
2022
- 2022-03-23 CN CN202210290138.4A patent/CN114558076A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101596310A (en) * | 2008-06-02 | 2009-12-09 | 彭强 | A kind of artificial substrate membrane emulsifying paste that is used for wound repair |
CN104940849A (en) * | 2015-07-29 | 2015-09-30 | 青岛蓝盛洋医药生物科技有限责任公司 | Traditional Chinese medicine preparation for treating boils through external application and preparation method of traditional Chinese medicine preparation |
CN105963518A (en) * | 2016-03-21 | 2016-09-28 | 经雷 | External-use liniment for treating scald |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091203A (en) | External traditional Chinese medicine preparation for treating chronic wounds and preparation method thereof | |
WO2009125182A1 (en) | A product for topical administration | |
CN103393953A (en) | Traditional Chinese medicine ointment for promoting postoperative wound healing, and preparation method thereof | |
CN104857312A (en) | Traditional Chinese medicine composition for preventing and controlling wound infection and promoting wound repair | |
CN1915351A (en) | Composition of Chinese traditional medicine in use for treating burn and scald, and product for resolving poxes, and preparation method | |
CN106581439A (en) | Traditional Chinese medicine composition for treating wounds, diabetic feet and skin ulceration, and preparation method thereof | |
CN109010520A (en) | A kind of ointment and preparation method thereof for treating dark sore | |
CN114558076A (en) | Pure natural cattail pollen honeycomb element skin wound hemostasis and analgesia cream and preparation method thereof | |
CN105168091A (en) | Telangiectasis removing mask powder and preparation method thereof | |
KR20120137134A (en) | Pharmaceutical composition for burn treatment using gombo-baechu | |
CN110624032A (en) | Ointment for treating burns and scalds and preparation method thereof | |
CN104623040A (en) | Nursing composition with wound sterilization and inflammation diminishment effects and preparation method thereof | |
CN107875285B (en) | Chinese medicinal preparation and its preparation method | |
CN109045204A (en) | A kind of herb liquid and preparation method thereof for treating burn and scald | |
CN104306734B (en) | Treat diabetic gangrene externally applied ointment preparation and preparation method thereof | |
CN110403995B (en) | Traditional Chinese medicine composition for treating superficial phlebitis and preparation, use methods and application thereof | |
CN115414415B (en) | A Chinese medicinal composition for treating skin injury and ulcer, and its preparation method | |
CN103394009B (en) | Traditional Chinese medicine for treating trauma and diabetes foot ulcer and preparation method | |
CN111437343B (en) | Inflammation-diminishing and pain-relieving composition, carthamus tinctorius inflammation-diminishing and pain-relieving liquid and preparation method thereof | |
CN106109854A (en) | A kind of pharmaceutical composition promoting skin wound healing | |
CN105125801B (en) | Spray for relieving itching of puerpera incision and preparation method | |
CN1539463A (en) | Multifunctional health care fluid for nursing skin | |
CN104940378A (en) | Traditional Chinese medicine preparation for treating oral ulcer | |
CN105560343A (en) | Traditional Chinese medicine composition for treating neonatal omphalitis | |
CN105343266A (en) | Psoriasis treating ointment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220531 |
|
RJ01 | Rejection of invention patent application after publication |